Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **human intestinal microbiota** refers to the diverse community of microorganisms—including bacteria, archaea, fungi, and viruses—that reside within the human gastrointestinal (GI) tract, primarily the large intestine[1][2][3][5]. This ecosystem contributes key functions to host physiology, including fermentation of otherwise indigestible dietary components, synthesis of vitamins, protection against pathogenic microbes, shaping of the immune system, energy harvest, and maintenance of intestinal barrier integrity[1][2][3]. The microbiota is predominantly composed of bacteria from the phyla Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria, comprising hundreds of distinct species, with proportions varying between individuals and across life stages or disease states[1][2][3][5]. Dysbiosis, or imbalance in the microbial community, has been implicated in a range of diseases—including inflammatory, metabolic, autoimmune, and infectious conditions—prompting research and therapeutic interest in approaches such as probiotics, prebiotics, antibiotics, and fecal microbiota transplantation[1][2][3]. Importantly, the human intestinal microbiota is a **complex biological community** rather than a single molecular entity or canonical drug target, so it does not fit traditional definitions of receptor, enzyme, transporter, etc., but instead is a dynamic multicellular ecosystem with wide-ranging systemic effects[1][2][3].
Modulation of microbial composition and diversity. Restoration of eubiosis (microbial balance) or disruption (dysbiosis). Alteration of short-chain fatty acid production. Regulation of host immune responses. Enhancement of colonization resistance to pathogens.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human intestinal microbiota.